KLOW – 80mg

This combination integrates a copper binding tripeptide complex, a pentadecapeptide fragment, a thymosin derived actin regulatory peptide, and a tripeptide fragment derived from alpha melanocyte stimulating hormone. The formulation is utilized in in vitro and in vivo experimental models investigating coordinated cellular signaling, extracellular matrix regulation, cytoskeletal dynamics, and immunomodulatory pathways.
In controlled laboratory settings, KLOW has been evaluated for its activity across multiple biological systems, including:
• Actin Binding and Cytoskeletal Regulation – examined for TB-500 associated modulation
of actin polymerization and cellular structural organization
• Extracellular Matrix and Tissue Remodeling Pathways – investigated for peptide mediated
signaling related to collagen regulation and matrix protein dynamics associated with BPC-157
and GHK-Cu
• Copper Dependent Cellular Signaling – studied for GHK-Cu mediated metal ion transport,
trace element availability, and gene expression modulation
• Immunoregulatory and Inflammatory Signaling Pathways – evaluated for KPV associated
modulation of cytokine related signaling and cellular inflammatory response mechanisms
This coordinated peptide blend continues to serve as a research tool for investigating integrated
cytoskeletal regulation, extracellular matrix biology, trace metal peptide interactions, and
immune signaling dynamics within preclinical experimental models.